Results 251 to 260 of about 489,406 (280)
Some of the next articles are maybe not open access.
International Urogynecology Journal and Pelvic Floor Dysfunction, 1999
Bladder cancer is seen mainly in men. The incidence in women is increasing, but is still approximately three to four times lower than in men. In particular transitional cell cancers seem relatively more common in men then in women (ratio 4:1), but non-transitional cell cancer is also more frequent in men (ratio 2.7: 1).
Poel, H.G. van der +2 more
openaire +4 more sources
Bladder cancer is seen mainly in men. The incidence in women is increasing, but is still approximately three to four times lower than in men. In particular transitional cell cancers seem relatively more common in men then in women (ratio 4:1), but non-transitional cell cancer is also more frequent in men (ratio 2.7: 1).
Poel, H.G. van der +2 more
openaire +4 more sources
Current Opinion in Oncology, 2007
This article reviews the diagnosis and management of bladder cancer with an emphasis on studies and developments over the past year.Cystoscopy remains the mainstay in the detection and surveillance of bladder cancer, though efforts continue in the development of urinary bladder cancer markers.
openaire +2 more sources
This article reviews the diagnosis and management of bladder cancer with an emphasis on studies and developments over the past year.Cystoscopy remains the mainstay in the detection and surveillance of bladder cancer, though efforts continue in the development of urinary bladder cancer markers.
openaire +2 more sources
European Urology, 2008
Patients with bladder cancer face a variable risk of recurrence based on their clinical characteristics and the biology of their disease. Physicians need tools to accurately estimate the risk of recurrence and cancer-specific mortality to recommend individualized therapy and to design appropriate clinical trials.A MEDLINE literature search was ...
Shariat Shahrokh F. +4 more
openaire +3 more sources
Patients with bladder cancer face a variable risk of recurrence based on their clinical characteristics and the biology of their disease. Physicians need tools to accurately estimate the risk of recurrence and cancer-specific mortality to recommend individualized therapy and to design appropriate clinical trials.A MEDLINE literature search was ...
Shariat Shahrokh F. +4 more
openaire +3 more sources
Epidemiology of Bladder Cancer
European Urology, 1999Item does not contain ...
Aben, K.K.H., Kiemeney, L.A.L.M.
openaire +4 more sources
Treatment of muscle‐invasive and advanced bladder cancer in 2020
Ca-A Cancer Journal for Clinicians, 2020Vaibhav G Patel +2 more
exaly
The role of the HIF‐1α/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer
Cancer Communications, 2021Qiang Lu, Ji-fu Wei, Haiwei Yang
exaly